Journal of Preventive Medicine and Public Health

English Abstracts

A Comparative Study on Comorbidity Measurements with Lookback Period using Health Insurance Database: Focused on Patients Who Underwent Percutaneous Coronary Intervention.: Kyoung Hoon Kim, Lee Su Ahn; J Prev Med Public Health. 2009;42(4):267-273.; DOI: https://doi.org/10.3961/jpmph.2009.42.4.267

5,342 View
109 Download
13 Crossref

OBJECTIVES
To compare the performance of three comorbidity measurements (Charlson comorbidity index, Elixhauser's comorbidity and comorbidity selection) with the effect of different comorbidity lookback periods when predicting in-hospital mortality for patients who underwent percutaneous coronary intervention. METHODS: This was a retrospective study on patients aged 40 years and older who underwent percutaneous coronary intervention. To distinguish comorbidity from complications, the records of diagnosis were drawn from the National Health Insurance Database excluding diagnosis that admitted to the hospital. C-statistic values were used as measures for in comparing the predictability of comorbidity measures with lookback period, and a bootstrapping procedure with 1,000 replications was done to determine approximate 95% confidence interval. RESULTS: Of the 61,815 patients included in this study, the mean age was 63.3 years (standard deviation: +/-10.2) and 64.8% of the population was male. Among them, 1,598 (2.6%) had died in hospital. While the predictive ability of the Elixhauser s comorbidity and comorbidity selection was better than that of the Charlson comorbidity index, there was no significant difference among the three comorbidity measurements. Although the prevalence of comorbidity increased in 3 years of lookback periods, there was no significant improvement compared to 1 year of a lookback period. CONCLUSIONS: In a health outcome study for patients who underwent percutaneous coronary intervention using National Health Insurance Database, the Charlson comorbidity index was easy to apply without significant difference in predictability compared to the other methods. The one year of observation period was adequate to adjust the comorbidity. Further work to select adequate comorbidity measurements and lookback periods on other diseases and procedures are needed.

Summary

Citations

Citations to this article as recorded by

Adjusting for Confounders in Outcome Studies Using the Korea National Health Insurance Claim Database: A Review of Methods and Applications
Seung Jin Han, Kyoung Hoon Kim
Journal of Preventive Medicine and Public Health.2024; 57(1): 1. CrossRef
High‐Intensity Statin Reduces the Risk of Mortality Among Chronic Liver Disease Patients With Atherosclerotic Cardiovascular Disease: A Population‐Based Cohort Study
Sungho Bea, In‐Sun Oh, Ju Hwan Kim, Dong Hyun Sinn, Yoosoo Chang, Seungho Ryu, Ju‐Young Shin
Journal of the American Heart Association.2023;[Epub] CrossRef
Impact of comorbidity assessment methods to predict non-cancer mortality risk in cancer patients: a retrospective observational study using the National Health Insurance Service claims-based data in Korea
Sanghee Lee, Yoon Jung Chang, Hyunsoon Cho
BMC Medical Research Methodology.2021;[Epub] CrossRef
Evaluating the impact of covariate lookback times on performance of patient-level prediction models
Jill Hardin, Jenna M. Reps
BMC Medical Research Methodology.2021;[Epub] CrossRef
Comorbidity and cervical cancer survival of Indigenous and non-Indigenous Australian women: A semi-national registry-based cohort study (2003-2012)
Abbey Diaz, Peter D. Baade, Patricia C. Valery, Lisa J. Whop, Suzanne P. Moore, Joan Cunningham, Gail Garvey, Julia M. L. Brotherton, Dianne L. O’Connell, Karen Canfell, Diana Sarfati, David Roder, Elizabeth Buckley, John R. Condon, Stéphanie Filleur
PLOS ONE.2018; 13(5): e0196764. CrossRef
Comorbidity Adjustment in Health Insurance Claim Database
Kyoung Hoon Kim
Health Policy and Management.2016; 26(1): 71. CrossRef
The Benefits Conferred by Radial Access for Cardiac Catheterization Are Offset by a Paradoxical Increase in the Rate of Vascular Access Site Complications With Femoral Access
Lorenzo Azzalini, Kunle Tosin, Malorie Chabot-Blanchet, Robert Avram, Hung Q. Ly, Benoit Gaudet, Richard Gallo, Serge Doucet, Jean-François Tanguay, Réda Ibrahim, Jean C. Grégoire, Jacques Crépeau, Raoul Bonan, Pierre de Guise, Mohamed Nosair, Jean-Franço
JACC: Cardiovascular Interventions.2015; 8(14): 1854. CrossRef
A Convergence Study in the Severity-adjusted Mortality Ratio on inpatients with multiple chronic conditions
Young-Suk Seo, Sung-Hong Kang
Journal of Digital Convergence.2015; 13(12): 245. CrossRef
Development and validation of comorbidity index in South Korea
S.-R. Kil, S.-I. Lee, Y.-H. Khang, M.-S. Lee, H.-J. Kim, S.-O. Kim, M.-W. Jo
International Journal for Quality in Health Care.2012; 24(4): 391. CrossRef
Development of Mortality Model of Severity-Adjustment Method of AMI Patients
Ji-Hye Lim, Mun-Hee Nam
Journal of the Korea Academia-Industrial cooperation Society.2012; 13(6): 2672. CrossRef
Use of hospitalisation history (lookback) to determine prevalence of chronic diseases: impact on modelling of risk factors for haemorrhage in pregnancy
Jian Sheng Chen, Christine L Roberts, Judy M Simpson, Jane B Ford
BMC Medical Research Methodology.2011;[Epub] CrossRef
The Impact of Medicaid Expansion to include population with low income on the preventable hospitalizations
Hyun-Chul Shin, Se-Ra Kim
Korean Journal of Health Policy and Administration.2010; 20(1): 87. CrossRef
Comparative Study on Three Algorithms of the ICD-10 Charlson Comorbidity Index with Myocardial Infarction Patients
Kyoung Hoon Kim
Journal of Preventive Medicine and Public Health.2010; 43(1): 42. CrossRef

Does a Higher Coronary Artery Bypass Graft Surgery Volume Always have a Low In-hospital Mortality Rate in Korea?.: Kwang Soo Lee, Sang Il Lee; J Prev Med Public Health. 2006;39(1):13-20.

2,094 View
30 Download

Abstract PDF: OBJECTIVES
To propose a risk-adjustment model with using insurance claims data and to analyze whether or not the outcomes of non-emergent and isolated coronary artery bypass graft surgery (CABG) differed between the low- and high-volume hospitals for the patients who are at different levels of surgical risk. METHODS: This is a cross-sectional study that used the 2002 data of the national health insurance claims. The study data set included the patient level data as well as all the ICD-10 diagnosis and procedure codes that were recorded in the claims. The patient's biological, admission and comorbidity information were used in the risk-adjustment model. The risk factors were adjusted with the logistic regression model. The subjects were classified into five groups based on the predicted surgical risk: minimal (<0.5%), low (0.5% to 2%), moderate (2% to 5%), high (5% to 20%), and severe (=20%). The differences between the low- and high-volume hospitals were assessed in each of the five risk groups. RESULTS: The final risk-adjustment model consisted of ten risk factors and these factors were found to have statistically significant effects on patient mortality. The C-statistic (0.83) and Hosmer-Lemeshow test (x2=6.92, p=0.55) showed that the model's performance was good. A total of 30 low-volume hospitals (971patients) and 4 high-volume hospitals (1,087patients) were identified. Significantdifferences for the in-hospital mortality were found between the low- and high-volume hospitals for the high (21.6% vs. 7.2%, p=0.00) and severe (44.4% vs. 11.8%, p=0.00) risk patient groups. CONCLUSIONS: Good model performance showed that insurance claims data can be used for comparing hospital mortality after adjusting for the patients' risk. Negative correlation was existed between surgery volume and in-hospital mortality. However, only patients in high and severe risk groups had such a relationship.; Summary

First
Prev
Page of 1
Next
Last

Search